Annual Drug Patent Expirations for NEOPROFEN
Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has twelve patent family members in six countries.
The generic ingredient in NEOPROFEN is ibuprofen lysine. Two suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com